AAAAAA

   
Results: 1-14 |
Results: 14
The effects of transdermal and oral estrogen/progesterone regimens on freeand total protein S in postmenopausal women
Authors: Marque, V Alhenc-Gelas, M Plu-Bureau, G Oger, E Scarabin, PY
Citation: V. Marque et al., The effects of transdermal and oral estrogen/progesterone regimens on freeand total protein S in postmenopausal women, THROMB HAEM, 86(2), 2001, pp. 713-714
Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy - Time-dependent change in transdermal,but not oral estrogen users
Authors: Oger, E Alhenc-Gelas, M Plu-Bureau, G Mennen, L Cambillau, M Guize, L Pujol, Y Scarabin, PY
Citation: E. Oger et al., Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy - Time-dependent change in transdermal,but not oral estrogen users, THROMB RES, 101(2), 2001, pp. 35-43
Resumption of luteinizing hormone pulsatility and hypogonadotropic hypogonadism after endoscopic ventriculocisternostomy in a hydrocephalic patient
Authors: Touraine, P Plu-Bureau, G Beressi, N Decq, P Thalabard, JC Kuttenn, F
Citation: P. Touraine et al., Resumption of luteinizing hormone pulsatility and hypogonadotropic hypogonadism after endoscopic ventriculocisternostomy in a hydrocephalic patient, FERT STERIL, 76(2), 2001, pp. 390-393
Long-term follow-up of 246 hyperprolactinemic patients
Authors: Touraine, F Plu-Bureau, G Beji, C Mauvais-Jarvis, F Kuttenn, F
Citation: F. Touraine et al., Long-term follow-up of 246 hyperprolactinemic patients, ACT OBST SC, 80(2), 2001, pp. 162-168
Breastfeeding and risk of breast cancer: a metaanalysis of published studies
Authors: Bernier, MO Plu-Bureau, G Bossard, N Ayzac, L Thalabard, JC
Citation: Mo. Bernier et al., Breastfeeding and risk of breast cancer: a metaanalysis of published studies, HUM REP UPD, 6(4), 2000, pp. 374-386
Oral contraception and genetic factors in breast cancer: characteristics and limits of case-only studies
Authors: Plu-Bureau, G Bossard, N Thalabard, JC
Citation: G. Plu-bureau et al., Oral contraception and genetic factors in breast cancer: characteristics and limits of case-only studies, REV EPIDEM, 48(3), 2000, pp. 294-303
Plasma 17 beta estradiol is inversely correlated with circulating vascularcell adhesion molecule
Authors: Oger, E Alhenc-Gelas, M Plu-Bureau, G Guize, L Scarabin, PY
Citation: E. Oger et al., Plasma 17 beta estradiol is inversely correlated with circulating vascularcell adhesion molecule, THROMB HAEM, 84(6), 2000, pp. 1125-1125
Epidemiology and treatment of benign breast disease: Effect of progestins on breast disease
Authors: Sitruk-Ware, R Plu-Bureau, G
Citation: R. Sitruk-ware et G. Plu-bureau, Epidemiology and treatment of benign breast disease: Effect of progestins on breast disease, PROGESTINS AND ANTIPROGESTINS IN CLINICAL PRACTICE, 2000, pp. 327-340
Percutaneous progesterone use and risk of breast cancer: Results from a French cohort study of premenopausal women with benign breast disease
Authors: Plu-Bureau, G Le, MG Thalabard, JC Sitruk-Ware, R Mauvais-Jarvis, P
Citation: G. Plu-bureau et al., Percutaneous progesterone use and risk of breast cancer: Results from a French cohort study of premenopausal women with benign breast disease, CANCER DET, 23(4), 1999, pp. 290-296
Hormone replacement therapy and circulating ICAM-1 in postmenopausal women- A randomised controlled trial
Authors: Scarabin, PY Alhenc-Gelas, M Oger, E Plu-Bureau, G
Citation: Py. Scarabin et al., Hormone replacement therapy and circulating ICAM-1 in postmenopausal women- A randomised controlled trial, THROMB HAEM, 81(5), 1999, pp. 673-675
Hormone replacement therapy and cardiovascular risk
Authors: Plu-Bureau, G
Citation: G. Plu-bureau, Hormone replacement therapy and cardiovascular risk, THERAPIE, 54(3), 1999, pp. 375-380
Interactions between estradiol and progesterone in normal breast - Implications for mammary carcinogenesis
Authors: Plu-Bureau, G Touraine, P Marvais-Jarvis, P
Citation: G. Plu-bureau et al., Interactions between estradiol and progesterone in normal breast - Implications for mammary carcinogenesis, CONT ENDOC, 11, 1999, pp. 21-37
Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia
Authors: Touraine, P Deneux, C Plu-Bureau, G Mauvais-Jarvis, P Kuttenn, F
Citation: P. Touraine et al., Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia, J ENDOC INV, 21(11), 1998, pp. 732-736
Interaction between genetic and hormonal factors in breast cancer
Authors: Plu-Bureau, G Thalabard, JC
Citation: G. Plu-bureau et Jc. Thalabard, Interaction between genetic and hormonal factors in breast cancer, ANN ENDOCR, 59(6), 1998, pp. 465-469
Risultati: 1-14 |